Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27,712,115
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
35,417,634
-
Shares change
-
-381,984
-
Total reported value, excl. options
-
$468,934,603
-
Value change
-
-$87,874,690
-
Put/Call ratio
-
157%
-
Number of buys
-
66
-
Number of sells
-
-85
-
Price
-
$13.24
Significant Holders of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) as of Q4 2024
204 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, $0.01 par value as of Q4 2024.
ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,417,634 shares
.
Largest 10 shareholders include EcoR1 Capital, LLC (7,873,448 shares), FMR LLC (3,030,236 shares), BlackRock, Inc. (2,548,468 shares), VANGUARD GROUP INC (1,843,740 shares), Fairmount Funds Management LLC (1,816,466 shares), Frazier Life Sciences Management, L.P. (1,573,719 shares), TANG CAPITAL MANAGEMENT LLC (1,330,879 shares), Boxer Capital Management, LLC (1,300,000 shares), STATE STREET CORP (1,285,755 shares), and Camber Capital Management LP (1,250,000 shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.